Loading company details...
Latest Form 4 (Nov 13, 2026): Elizabeth Forminard (EVP, Chief Legal Officer): Exercise/Conversion of 13,072 shares, $1.98M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | Elizabeth Forminard, EVP, Chief Legal Officer | Exercise/Conversion | 13,072 | $1.98M |
| Sep 11, 2026 | Daniel E. Pinto | Grant/Award | 113 | $31.3K |
| Sep 11, 2026 | Eugene A. Woods | Grant/Award | 136 | $37.5K |
| Sep 11, 2026 | Marillyn A. Hewson | Grant/Award | 181 | $50.0K |
| Sep 4, 2026 | Timothy Schmid, EVP, WW Chair, MedTech | Exercise/Conversion | 11,070 | $1.46M |
| Aug 18, 2026 | Jennifer L. Taubert, EVP, WWC. Innovative Medicine | Exercise/Conversion | 15,000 | $1.74M |
| Aug 14, 2026 | Joaquin Duato, CEO and Chairman of the Board | Exercise/Conversion | 123,291 | $14.26M |
| Aug 7, 2026 | Joaquin Duato, CEO and Chairman of the Board | Sale | 41,957 | $10.83M |
| Aug 7, 2026 | Elizabeth Forminard, EVP, Chief Legal Officer | Exercise/Conversion | 9,344 | $1.23M |
| Jul 21, 2026 | Vanessa Broadhurst, EVP, Global Corp Affairs | Exercise/Conversion | 11,129 | $1.44M |